Ligand-Sensitised LaF3 :Eu3+ and SrF2 :Eu3+ Nanoparticles and in Vitro Haemocompatiblity Studies

ChemMedChem. 2021 May 18;16(10):1640-1650. doi: 10.1002/cmdc.202100028. Epub 2021 Feb 25.

Abstract

Luminescent Ln3+ -doped nanoparticles (NPs) functionalised with the desired organic ligand molecules for haemocompatibility studies were obtained in a one-pot synthesis. Chelated aromatic organic ligands such as isophthalic acid, terephthalic acid, ibuprofen, aspirin, 1,2,4,5-benzenetetracarboxylic acid, 2,6-pyridine dicarboxylic acid and adenosine were applied for surface functionalisation. The modification of the nanoparticles is based on the donor-acceptor character of the ligand-nanoparticle system, which is an alternative to covalent functionalisation by peptide bonding as presented in our recent report. The aromatic groups of selected ligands absorb UV light and transfer their excited-state energy to the dopant Eu3+ ions in LaF3 and SrF2 NPs. Herein, we discuss the structural and spectroscopic characterisation of the NPs and the results of haemocompatibility studies. Flow cytometry analysis of the nanoparticles' membrane-binding is also presented.

Keywords: energy transfer; haemocompatibility; human erythrocytes; ligand sensitisation; luminescent nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Erythrocytes / drug effects*
  • Europium / chemistry
  • Europium / pharmacology*
  • Fluorides / chemistry
  • Fluorides / pharmacology*
  • Humans
  • Lanthanum / chemistry
  • Lanthanum / pharmacology*
  • Ligands
  • Molecular Structure
  • Nanoparticles / chemistry*
  • Strontium / chemistry
  • Strontium / pharmacology*
  • Structure-Activity Relationship

Substances

  • Ligands
  • lanthanum trifluoride
  • Europium
  • Lanthanum
  • Fluorides
  • Strontium